Outcomes of a Comprehensive, Pharmacist-Managed Injectable Anticoagulation Discharge Program for the Prophylaxis and Treatment of Venous Thromboembolism

被引:2
|
作者
Reger, Melissa A. [1 ]
Chapman, Jamie L. [2 ]
Lutomski, Dave M. [3 ,4 ]
Mueller, Eric W. [4 ,5 ]
机构
[1] Community Reg Med Ctr, Dept Pharm, Burn Surg, Fresno, CA USA
[2] Blount Mem Hosp, Dept Pharm Serv, Internal Med, Maryville, TN 37804 USA
[3] Univ Cincinnati Hlth, Univ Hosp, Dept Pharm Serv, Surg Trauma, Cincinnati, OH USA
[4] Univ Cincinnati, Clin Pharm, Div Pharm Practice, James L Winkle Coll Pharm, Cincinnati, OH USA
[5] Univ Cincinnati Hlth, Univ Hosp, Dept Pharm Serv, Crit Care, Cincinnati, OH USA
关键词
D O I
10.1177/875512251102700502
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Safe and effective transition of patients receiving injectable anticoagulation, from an inpatient to an outpatient setting, requires patient education, prescription coordination, and appropriate follow-up. Objective: To evaluate a long-standing, hospital-wide, pharmacist-managed injectable anticoagulation discharge program at an urban academic medical center. Methods: This observational study included adults discharged on an injectable anticoagulant between December 1, 2008, and February 28, 2009. The primary endpoint was program adherence, defined as percent of discharged patients whose anticoagulation therapy was coordinated by a pharmacist. Secondary endpoints included duration of patient counseling and medication procurement (including confirmation of current home supply or need for complete procurement of a full/new prescription); length of hospital stay for patients with a primary diagnosis of venous thromboembolism (VTE); and VTE recurrence and bleeding rates at 3 months. Descriptive statistics were used and are presented as proportions and mean (SD). Results: A total of 207 patients discharged on an injectable anticoagulant (3.2 discharges/day) were included. Pharmacist coordination was documented for 180 (87%) patients. Overall, pharmacists spent 37.6 (25.5) minutes per patient, including 19.4 (9.6) minutes for counseling and 19.7 (19.7) minutes for medication procurement; 150 (83%) patients required complete medication procurement lasting 21.4 (19.6) minutes. The length of hospital stay for patients with a primary diagnosis of VTE was 3.2 (2.4) days. At 3 months, 5.3% and 1.4% of assessable patients had recurrent VTE or major bleeding events, respectively. Patients with major bleeding experienced intracranial hemorrhage (n = 2) and gastrointestinal bleeding (n = 1), all beyond the first 2 weeks after discharge. Conclusions: The pharmacist-managed injectable anticoagulation discharge program was completed in a large proportion of patients. Patient education and medication procurement require the majority of time-related resources. Continual process improvement is crucial for hospitals to ensure that all patients discharged with injectable anticoagulation are assessed and receive anticoagulation education.
引用
收藏
页码:199 / 205
页数:7
相关论文
共 48 条
  • [41] Is Adherence to the American College of Chest Physicians Recommended Anticoagulation Treatment Duration Associated With Different Outcomes Among Patients With Venous Thromboembolism?
    Spyropoulos, Alex C.
    Preblick, Ron
    Kwong, Winghan J.
    Lingohr-Smith, Melissa
    Lin, Jay
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2017, 23 (06) : 532 - 541
  • [42] Is Adherence to the American College of Chest Physicians Recommended Anticoagulation Treatment Duration Associated with Different Outcomes Among Patients with Venous Thromboembolism?
    Spyropoulos, Alex C.
    Preblick, Ron
    Kwong, Jackie
    Lingohr-Smith, Melissa
    Lin, Jay
    BLOOD, 2015, 126 (23)
  • [43] IMPACT OF A POST-DISCHARGE VENOUS THROMBOEMBOLISM (VTE) PROPHYLAXIS PROGRAM IN PATIENTS UNDERGOING SURGERY FOR COLORECTAL CANCER OR INFLAMMATORY BOWEL DISEASE (IBD)
    Najjar, P. A.
    Madenci, A. L.
    Melnitchouk, N.
    Irani, J.
    Goldberg, J.
    Bleday, R.
    DISEASES OF THE COLON & RECTUM, 2018, 61 (05) : E232 - E232
  • [44] Relevance of systematic venographic outcomes in venous thromboembolism (VTE) prophylaxis studies:: Lessons from the pentasaccharide (fondaparinux, Arixtra®) clinical program.
    Bauer, KA
    Eriksson, BI
    Lassen, MR
    Turpie, AGG
    BLOOD, 2001, 98 (11) : 272A - 272A
  • [45] Venous Thromboembolism after Hospital Discharge: Temporal Trends in Baseline Characteristics, Prevention, Treatment, and 90-day Outcomes
    Brenner, Benjamin
    Tzoran, Inna
    Bikdeli, Behnood
    Valle, Reina
    Poenou, Geraldine
    Tirado-Mianda, Raimundo
    Pesce, Maria L.
    Pagan-Escribano, Javier
    Giorgi-Pierfranceschi, Matteo
    Monreal, Manuel
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2025, 51 (03): : 301 - 311
  • [46] A Pharmacist-Managed Hydroxyurea Prescribing Protocol Improves Uptake and Optimization Among Patients with Sickle Cell Disease within the Southern Alberta Rare Blood and Bleeding Disorders (SARBBD) Comprehensive Care Program
    Roessner, Cameron
    Sale, Trudy
    Poon, Man-Chiu
    Goodyear, Dawn
    Lee, Adrienne
    Rydz, Natalia
    BLOOD, 2021, 138 : 1896 - +
  • [47] Clinical outcomes of edoxaban treatment without parenteral anticoagulation therapy for acute venous thromboembolism: Insight from the COMMAND VTE Registry-2
    Tsujisaka, Y.
    Yamashita, Y.
    Chatani, R.
    Kaneda, K.
    Nishimoto, Y.
    Ikeda, N.
    Nishikawa, R.
    Ono, K.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [48] Balancing Venous Thromboembolism Prophylaxis and Hematoma in Breast Surgery Patients-Comparison of 30-Day Outcomes From the National Surgical Quality Improvement Program
    Lovely, Jenna
    Nehring, Sharon
    Boughey, Judy
    Degnim, Amy
    Donthi, Rajakumar
    Harmsen, W. Scott
    Jakub, James
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : 3 - 3